Circadian robustness as an independent predictor of prolonged progression-free survival (PFS) and overall survival (OS) in 436 patients with metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Levi, Francis
Parganiha, Arti
Karaboue, Abdoulaye
Innominato, Pasquale F.
Giacchetti, Sylvie
Garufi, Carlo
Dispersyn, Garance
Focan, C. N. J.
Iacobelli, Stefano
Bjarnason, Georg A.
Moreau, Thierry
Dugue, Pierre Antoine
Waterhouse, Jim
机构：
[1] Serv Chronotherapie, INSERM, Dep Cancerol, Hop Paul Brousse,U776, Villejuif, France
[2] Pt Ravishankar Shukla Univ, Sch Life Sci, Raipur, Madhya Pradesh, India
[3] Hop Paul Brousse, INSERM, U776, Villejuif, France
[4] INSERM, U776, Paris, France
[5] Regina Elena Inst Canc Res, Rome, Italy
[6] INSERM, Hop Paul Brousse, U776, Villejuif, France
[7] CHC Clin St Joseph, Liege, Belgium
[8] Univ G dAnnunzio, Chieti, Italy
[9] Mediapharma srl, Chieti, Italy
[10] Univ Toronto, Div Med Oncol Hematol, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[11] Hop Paul Brousse, INSERM, Res Epidemiol & Biostat, U780, Villejuif, France
[12] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
464
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [32] Evaluation of overall survival (OS), progression-free survival (PFS), or time to progression (TTP) in systematic review of randomized clinical trials (RCT) in patients with metastatic breast cancer (MBC)
    Mukonje, Terence
    Santana-Davila, Rafael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Prolonged progression-free survival in metastatic breast cancer
    Mayor, Susan
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 378 - 378
  • [34] Examples of Population Kinetics (PopKin) Assessments of Progression-Free (PFS) and Overall Survival (OS)
    Stewart, D.
    Aljassim Alshareef, A.
    Robinson, A.
    Fung-Kee-Fung, M.
    Ong, M.
    Awan, A.
    Ocana, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1213 - S1213
  • [35] Association of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (aEGFR) therapy.
    Lee, Michael Sangmin
    Advani, Shailesh M.
    Morris, Jeffrey
    Jiang, Zhi-Qin
    Manyam, Ganiraju C.
    Menter, David
    Broom, Bradley McIntosh
    Eng, Cathy
    Overman, Michael J.
    Maru, Dipen M.
    Hamilton, Stanley R.
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Circulating tumor cells in metastatic breast cancer: Are they a strong and independent predictor of poor progression-free and overall survival?
    Wallwiener, Markus
    Schneeweiss, Andreas
    Baccelli, Irene
    Riethdorf, Sabine
    Pantel, Klaus
    Marme, Frederik
    Schott, Sarah
    Trumpp, Andreas
    Taran, Florin-Andrei
    Hahn, Markus
    Schuetz, Florian
    Mueller, Volkmar
    Rack, Brigitte Kathrin
    Sohn, Christof
    Solomayer, Erich-Franz
    Janni, Wolfgang
    Hartkopf, Andreas D.
    Fehm, Tanja N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
  • [38] Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival
    Sun, Ryan
    Horiguchi, Miki
    Wei, Lee-Jen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1378 - 1379
  • [39] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    [J]. International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [40] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    Cohen, Steven J.
    Punt, Cornelis J. A.
    Iannotti, Nicholas
    Saidman, Bruce H.
    Sabbath, Kert D.
    Gabrail, Nashat Y.
    Picus, Joel
    Morse, Michael
    Mitchell, Edith
    Miller, M. Craig
    Doyle, Gerald V.
    Tissing, Henk
    Terstappen, Leon W. M. M.
    Meropol, Neal J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3213 - 3221
12345